« Previous
Next »
Journal of Surgical Research
Volume 153, Issue 1
, Pages 17-22
, 1 May 2009
Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction Through Mediating Survival and Preventing Apoptosis of Liver Cell
References
- . Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J. 1989;8:743
- The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 2003;17:1841
- . The pims and outs of survival signaling: Role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev. 2003;17:1813
- The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell. 1986;46:603
- Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 1995;14:2536
- KID-1, a protein kinase induced by depolarization in brain. J Biol Chem. 1998;273:16535
- Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene. 2000;19:1215
- Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene. 1997;15:1133
- . The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J. 1991;10:655
- Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 1989;56:673
- Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer. 2005;114:209
- Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene. 2000;19:1215
- Effect of coenzyme I on apoptosis of liver cell line L02 induced by ischemia-reperfusion injury. Di Yi Jun Yi Da Xue Xue Bao. 2002;22:512
- Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene. 1998;16:1587
- . Construction of shRNA targeted to the rat angiotensin II type 1 receptors and its RNAi in cytoplasma. J Huazhong Univ Sci Technol Med Sci. 2006;26:4
- Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells. Leukoc Res. 2007;31:515
- Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine. Biol Pharm Bull. 2006;29:907
- Mutations in FL5.12 cells conferring resistance to apoptosis induced by interleukin-3 deprivation. Int J Oncol. 1999;14:113
- Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood. 2003;101:3164
- Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood. 2005;105:4477
- Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res. 2005;3:443
- Pim-2 upregulation: Biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate. 2005;65:276
- Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 2004;64:6082
- The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem. 2003;278:45358
- Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol. 2006;7:1
PII: S0022-4804(08)00237-0
doi: 10.1016/j.jss.2008.03.033
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Surgical Research
Volume 153, Issue 1
, Pages 17-22
, 1 May 2009
